The company’ss Series A funding round was led by Ecoloab and saw participation from Pravega Ventures, Axilor Ventures, Techstars, and other angel investors
The startup will utilise the funding to refine its AI capabilities, expand its footprint and increase its reach to more customers
Founded in 2019, Leucine helps pharmaceutical companies leverage AI to digitise manufacturing workflows by replacing traditional paper-based compliance procedures with a digital-first approach
B2B software-as-a-service (SaaS) platform Leucine has raised $7 Mn as part of its Series A funding round led by Ecoloab. The round also saw participation from Pravega Ventures, Axilor Ventures, Techstars, and other angel investors.
The startup plans to utilise the funds to scale up its tech stack and refine its AI capabilities. The fresh capital will also be deployed to expand its footprint and increase its reach to more customers.